Dolby Laboratories Financials - Benzinga

Dolby Laboratories Inc

DLBNYSE

Trade with Public

Trade with Public

$61.50

-0.91-1.46%

At close: Aug 28, 5:00 PM EST

$61.50

N/A

After Hours: 4:35 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Dividends Compare Options Stock Report

Dolby Laboratories Financials

Dolby Laboratories (DLB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Dolby Laboratories Lowers FY2026 GAAP EPS Guidance from $2.66-$2.81 to $2.62-$2.77 vs $2.83 Est

Dolby Laboratories (NYSE:DLB) lowers FY2026 GAAP EPS guidance from $2.66-$2.81 to $2.62-$2.77 vs $2.83 analyst estimate..

Benzinga Newsdesk

PRO
Dolby Laboratories Lowers FY2026 Adj EPS Guidance from $4.30-$4.45 to $4.25-$4.40 vs $4.30 Est; Narrows FY2026 Sales Guidance from $1.400B-$1.450B to $1.410B-$1.440B vs $1.407B Est

Dolby Laboratories (NYSE:DLB) lowers FY2026 Adj EPS guidance from $4.30-$4.45 to $4.25-$4.40 vs $4.30 analyst estimate. Narrows FY2026 sales outlook from $1.400 billion-$1.450 billion to $1.410 billion-$1.440 billion vs

Benzinga Newsdesk

PRO
Dolby Laboratories Sees Q4 GAAP EPS $0.78-$0.93 vs $0.79 Est

Dolby Laboratories (NYSE:DLB) is looking for Q4 GAAP EPS of $0.78-$0.93 vs $0.79 analyst estimate..

Benzinga Newsdesk

PRO
Dolby Laboratories Sees Q4 Adj EPS $1.13-$1.28 vs $1.20 Est; Sees Sales $362.000M-$392.000M vs $351.950M Est

Dolby Laboratories (NYSE:DLB) is looking for Q4 Adj EPS of $1.13-$1.28 vs $1.20 analyst estimate. sees sales of $362.000 million-$392.000 million vs $351.950 million analyst estimate.

Benzinga Newsdesk

PRO
Dolby Laboratories Q3 Adj. EPS $0.69 Beats $0.67 Estimate, Sales $304.995M Miss $311.960M Estimate

Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $0.69 per share which beat the analyst consensus estimate of $0.67 by 2.99 percent. This is a 11.54 percent decrease over earnings of $0.78 per share from the

Benzinga Newsdesk

PRO
Dolby Laboratories Sees Q3 Adj EPS $0.56-$0.71 vs $0.98 Est; Sees Sales $295.000M-$325.000M vs $343.538M Est

Dolby Laboratories (NYSE:DLB) is looking for Q3 Adj EPS of $0.56-$0.71 vs $0.98 analyst estimate. sees sales of $295.000 million-$325.000 million vs $343.538 million analyst estimate.

Benzinga Newsdesk